Morningstar Investment Services LLC Ionis Pharmaceuticals Inc Transaction History

Morningstar Investment Services LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$31.71 - $43.0 $7.06 Million - $9.58 Million	-222,681 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$29.88 - $37.04 $97,080 - $120,342	3,249 Added 1.48%	222,681 $8 Million
Q4 2021 Feb 01, 2022	BUY	$25.61 - $35.1 $135,502 - $185,714	5,291 Added 2.47%	219,432 $6.68 Million
Q3 2021 Nov 12, 2021	BUY	$33.54 - $40.55 $135,300 - $163,578	4,034 Added 1.92%	214,141 $7.21 Million
Q2 2021 Aug 12, 2021	BUY	$34.54 - $47.25 $255,596 - $349,650	7,400 Added 3.65%	210,107 $8.31 Million
Q1 2021 May 11, 2021	BUY	$42.51 - $63.78 $8.62 Million - $12.9 Million	202,707 New	202,707 $9.06 Million

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.46B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Morningstar Investment Services LLC, based on Form 13F filings with the SEC.

Stay updated on Morningstar Investment Services LLC with notifications on news.